PMID- 27431398 OWN - NLM STAT- MEDLINE DCOM- 20170711 LR - 20231117 IS - 1866-3370 (Print) IS - 1866-3370 (Linking) VI - 32 DP - 2017 TI - Reinforcing Effects of Cathinone NPS in the Intravenous Drug Self-Administration Paradigm. PG - 133-143 LID - 10.1007/7854_2016_33 [doi] AB - Since the mid- to late 2000s, there has been a dramatic rise in the use and abuse of synthetic derivatives of cathinone, a stimulant alkaloid found in the African shrub Catha edulis. Cathinone novel psychoactive substances (NPS), also referred to as synthetic cathinones or "bath salt"-type drugs, have gained popularity among drug users due to their potency, low cost, ease of procurement, and diverse array of evolving chemical structures. While the ability of cathinone NPS to produce psychotomimetic effects, multiple organ system toxicity, and death in humans is well documented, there has been limited scientific investigation into the reinforcing effects and abuse liability of these drugs. In this chapter, we will summarize the existing literature on the reinforcing effects of cathinone NPS in rodents using the intravenous self-administration (IVSA) paradigm. We will also compare the ability of cathinone NPS to serve as reinforcers to that of classical psychostimulants such as cocaine, methamphetamine, and methylenedioxymethamphetamine (MDMA). The chapter will conclude with a summary and indications for future avenues of research on cathinone NPS. FAU - Watterson, Lucas R AU - Watterson LR AD - Department of Psychology, Arizona State University, 871104, Tempe, AZ, 85287, USA. FAU - Olive, M Foster AU - Olive MF AD - Department of Psychology, Arizona State University, 871104, Tempe, AZ, 85287, USA. foster.olive@asu.edu. LA - eng GR - R01 DA025606/DA/NIDA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Review PL - Germany TA - Curr Top Behav Neurosci JT - Current topics in behavioral neurosciences JID - 101535383 RN - 0 (Alkaloids) RN - 0 (Benzodioxoles) RN - 0 (Central Nervous System Stimulants) RN - 0 (Psychotropic Drugs) RN - 0 (Pyrrolidines) RN - 44RAL3456C (Methamphetamine) RN - 540EI4406J (cathinone) RN - I5Y540LHVR (Cocaine) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) RN - 0 (Synthetic Cathinone) SB - IM MH - Administration, Intravenous MH - Alkaloids/*pharmacology MH - Animals MH - Behavior, Animal/*drug effects MH - Benzodioxoles/pharmacology MH - Central Nervous System Stimulants/*pharmacology MH - Cocaine/pharmacology MH - Conditioning, Operant MH - Methamphetamine/pharmacology MH - N-Methyl-3,4-methylenedioxyamphetamine/pharmacology MH - Psychotropic Drugs/*pharmacology MH - Pyrrolidines/pharmacology MH - Rats MH - *Reinforcement, Psychology MH - *Self Administration MH - Synthetic Cathinone OTO - NOTNLM OT - Animal model OT - Cathinone OT - Intravenous self-administration OT - Operant conditioning OT - Reinforcement EDAT- 2016/07/20 06:00 MHDA- 2017/07/14 06:00 CRDT- 2016/07/20 06:00 PHST- 2016/07/20 06:00 [pubmed] PHST- 2017/07/14 06:00 [medline] PHST- 2016/07/20 06:00 [entrez] AID - 10.1007/7854_2016_33 [doi] PST - ppublish SO - Curr Top Behav Neurosci. 2017;32:133-143. doi: 10.1007/7854_2016_33.